{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-254620","form_type":"8-K","ticker":"AMRN","cik":"0000897448","company_name":"AMARIN CORP PLCUK","filed_at":"2025-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.537908+00:00","generated_at":"2026-05-17T01:49:26.573647+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Amarin Q3 net revenue $49.7M (+17% YoY), operating loss narrows 56% to $11.1M","bullets":["Total net revenue $49.7M, up 17% YoY, driven by US sales rebound and exclusive PBM status.","Operating loss of $11.1M improved from $25.2M; SG&A down 47% to $19.7M after restructuring.","Completed transition to fully partnered commercial model (Recordati in Europe); targeting positive free cash flow in 2026.","US product revenue $40.9M (+34% YoY); Europe $4.1M (-5%); Rest-of-World $3.6M (-48%).","Net loss $7.7M ($0.02 EPS) vs $25.1M ($0.06 EPS) last year; cash $286.6M, debt-free."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-254620","json":"https://secwatch.observer/filing/0001193125-25-254620.json","markdown":"https://secwatch.observer/filing/0001193125-25-254620.md","text":"https://secwatch.observer/filing/0001193125-25-254620.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/897448/000119312525254620/0001193125-25-254620-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/897448/000119312525254620/amrn-20251029.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:49:26.573647+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}